Drugs Made In America Acquisition Corp.
DMAA- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $124.9M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Drugs Made In America Acquisition Corp. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +6 vs. Q2 2025
- Shares held
- 21.8M
- +1.05M (+5.1%) vs. Q2 2025
- Total value
- $223.4M
- +$12.3M (+5.8%) vs. Q2 2025
- New holders
- 11
- 6 more added
- Sold out
- 5
- 9 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $124.9M |
| Q1 2026 | 39 | $237.3M |
| Q4 2025 | 39 | $232.1M |
| Q3 2025 | 37 | $223.4M |
| Q2 2025 | 32 | $212.3M |
| Q1 2025 | 24 | $171.3M |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Karpus Management, Inc. | 2,547,667 | $26.2M | 0.83% | −196,442−7.2% | Reduced |
| Vivaldi Asset Management, LLC | 2,242,500 | $23.0M | 1.49% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 1,900,000 | $19.5M | 0.40% | 00.0% | Unchanged |
| Glazer Capital, LLC | 1,822,292 | $18.7M | 0.63% | −1580.0% | Reduced |
| Westchester Capital Management, LLC | 1,669,000 | $17.1M | 0.89% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 1,550,000 | $15.9M | 0.10% | −250,000−13.9% | Reduced |
| Wolverine Asset Management LLC | 1,249,128 | $12.8M | 0.19% | +227,222+22.2% | Added |
| Mizuho Securities USA LLC | 1,100,447 | $11.3M | 0.23% | +180,660+19.6% | Added |
| Aristeia Capital LLC | 881,716 | $9.06M | 0.28% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 690,000 | $7.09M | 0.01% | 00.0% | Unchanged |
| Heights Capital Management, Inc | 650,000 | $6.68M | 2.12% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 528,100 | $5.42M | 0.34% | +401,378+316.7% | Added |
| Boothbay Fund Management, LLC | 500,000 | $5.13M | 0.13% | −70,000−12.3% | Reduced |
| Atw Spac Management LLC | 500,000 | $5.13M | 6.48% | −70,000−12.3% | Reduced |
| LMR Partners LLP | 500,000 | $5.13M | 0.07% | 00.0% | Unchanged |
| J. Goldman & Co LP | 500,000 | $5.13M | 0.19% | +500,000 | New |
| Toronto Dominion Bank | 450,000 | $4.62M | 0.01% | −50,000−10.0% | Reduced |
| Whitebox Advisors LLC | 400,000 | $4.11M | 0.08% | 00.0% | Unchanged |
| CNH Partners LLC | 371,211 | $3.81M | 0.10% | −5,103−1.4% | Reduced |
| Rivernorth Capital Management, LLC | 317,998 | $3.27M | 0.19% | +317,998 | New |
| Context Capital Management, LLC | 250,000 | $2.57M | 0.08% | +250,000 | New |
| Clear Street Group Inc. | 209,566 | $2.15M | 0.01% | +209,566 | New |
| Shaolin Capital Management LLC | 150,000 | $1.54M | 0.07% | +50,000+50.0% | Added |
| Bulldog Investors, LLP | 130,264 | $1.34M | 0.31% | +57,300+78.5% | Added |
| Goldman Sachs Group Inc | 119,686 | $1.23M | 0.00% | 00.0% | Unchanged |
| DLD Asset Management, LP | 113,672 | $1.17M | 0.15% | −75,050−39.8% | Reduced |
| JPMorgan Chase & Co | 99,690 | $1.02M | 0.00% | +99,690 | New |
| Warberg Asset Management LLC | 92,055 | $945.4K | 0.27% | 00.0% | Unchanged |
| Periscope Capital Inc. | 50,000 | $513.5K | 0.12% | +50,000 | New |
| Geode Capital Management, LLC | 45,648 | $468.8K | 0.00% | 00.0% | Unchanged |
| Dakota Wealth Management | 36,400 | $373.8K | 0.01% | +36,400 | New |
| HRT Financial LP | 27,487 | $282.0K | 0.00% | +27,487 | New |
| UBS Group AG | 20,121 | $206.6K | 0.00% | +20,120+2,012,000.0% | Added |
| Sandia Investment Management LP | 15,721 | $161.5K | 0.48% | +15,721 | New |
| Quarry LP | 15,721 | $161.5K | 0.04% | +15,721 | New |
| Governors Lane LP | 11,200 | $115.0K | 0.02% | +11,200 | New |
| Morgan Stanley | 32 | $329 | 0.00% | −77−70.6% | Reduced |
| Mangrove Partners | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −149,215−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Logan Stone Capital, LLC | 0 | $0 | 0.00% | −60,991−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −46,685−100.0% | Sold out |
| Clear Street LLC | – | – | – | – | Not filed |